study of benign prostatic hyperplasia cases with using kent repertory

Utility of Kent Repertory in Managment of cases of Benign Prostatic Hyperplasia - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/113120

Enrollment

Registered

2026-06-29

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Individualized Homoeopathic Medicine for 1 year: My purpose of work involves to effect of individualized homeopathic prescription in benign prostatic hyperplasia cases using kent Repert

Eligibility

Inclusion criteria

Inclusion criteria: Pre diagnosed cases of BPH. No Prior prostate - related surgical interventions. Patients willing to participate and provide informed consent.

Exclusion criteria

Exclusion criteria: Presence of any systemic or neurological disorder. History of irreversible pathological conditions. Patients taking any other alternative therapy along with homoepathic treatment. Any renal disease or condition other than BPH.

Design outcomes

Primary

Measure	Time frame
There will be some improvement after prescribingTimepoint: 15 days	—

Secondary

Measure	Time frame
to asses the change in symptomatology and IPSS score in the patient with BPH before and after homoeopathic treatmentTimepoint: after 15 days and end of treatment	—

Countries

India

Contacts

Public Contactdr hiral trivedi

rajkot homoeopathic medical college

hiral.trivedi1994@gmail.com7405820224

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026